1. Home
  2. LGI vs TIL Comparison

LGI vs TIL Comparison

Compare LGI & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGI
  • TIL
  • Stock Information
  • Founded
  • LGI 2004
  • TIL 2018
  • Country
  • LGI United States
  • TIL United States
  • Employees
  • LGI N/A
  • TIL N/A
  • Industry
  • LGI
  • TIL Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGI
  • TIL Health Care
  • Exchange
  • LGI Nasdaq
  • TIL Nasdaq
  • Market Cap
  • LGI 189.3M
  • TIL 171.7M
  • IPO Year
  • LGI N/A
  • TIL 2021
  • Fundamental
  • Price
  • LGI $15.52
  • TIL $13.23
  • Analyst Decision
  • LGI
  • TIL Buy
  • Analyst Count
  • LGI 0
  • TIL 5
  • Target Price
  • LGI N/A
  • TIL $114.00
  • AVG Volume (30 Days)
  • LGI 41.1K
  • TIL 179.4K
  • Earning Date
  • LGI 01-01-0001
  • TIL 05-20-2025
  • Dividend Yield
  • LGI 7.10%
  • TIL N/A
  • EPS Growth
  • LGI N/A
  • TIL N/A
  • EPS
  • LGI N/A
  • TIL N/A
  • Revenue
  • LGI N/A
  • TIL N/A
  • Revenue This Year
  • LGI N/A
  • TIL N/A
  • Revenue Next Year
  • LGI N/A
  • TIL N/A
  • P/E Ratio
  • LGI N/A
  • TIL N/A
  • Revenue Growth
  • LGI N/A
  • TIL N/A
  • 52 Week Low
  • LGI $12.66
  • TIL $9.62
  • 52 Week High
  • LGI $16.68
  • TIL $92.00
  • Technical
  • Relative Strength Index (RSI)
  • LGI 57.99
  • TIL 44.22
  • Support Level
  • LGI $15.34
  • TIL $11.97
  • Resistance Level
  • LGI $15.68
  • TIL $14.67
  • Average True Range (ATR)
  • LGI 0.25
  • TIL 2.05
  • MACD
  • LGI 0.12
  • TIL -0.04
  • Stochastic Oscillator
  • LGI 90.12
  • TIL 17.87

About LGI Lazard Global Total Return and Income Fund

Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: